Profil
Olaf Randerath is currently the Head-Medical Affairs at APONTIS PHARMA AG.
Prior to this, he worked as the Head-Development Projects at UCB Pharma GmbH and as the Head-Clinical Development at Schwarz Pharma Deutschland GmbH.
Postes actifs de Olaf Randerath
Sociétés | Poste | Début |
---|---|---|
APONTIS PHARMA AG | Chief Tech/Sci/R&D Officer | - |
Anciens postes connus de Olaf Randerath
Sociétés | Poste | Fin |
---|---|---|
Schwarz Pharma Deutschland GmbH | Corporate Officer/Principal | - |
UCB Pharma GmbH
UCB Pharma GmbH Pharmaceuticals: MajorHealth Technology UCB Pharma GmbH manufactures and develops drugs. It manufactures prescription and non-prescription drugs. With its partners, the company engages in biopharmaceutical research and development. Apart from providing medication, the company provides support to the patients. The company was founded in 1928 and is headquartered in Monheim, Germany. | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
APONTIS PHARMA AG | Health Technology |
Entreprise privées | 2 |
---|---|
UCB Pharma GmbH
UCB Pharma GmbH Pharmaceuticals: MajorHealth Technology UCB Pharma GmbH manufactures and develops drugs. It manufactures prescription and non-prescription drugs. With its partners, the company engages in biopharmaceutical research and development. Apart from providing medication, the company provides support to the patients. The company was founded in 1928 and is headquartered in Monheim, Germany. | Health Technology |
Schwarz Pharma Deutschland GmbH |